CVS Health Co. (NYSE:CVS) Position Boosted by Atomi Financial Group Inc.

Atomi Financial Group Inc. increased its holdings in CVS Health Co. (NYSE:CVS) by 11.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,384 shares of the pharmacy operator’s stock after buying an additional 2,127 shares during the quarter. Atomi Financial Group Inc.’s holdings in CVS Health were worth $1,282,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Deerfield Management Company L.P. Series C bought a new position in CVS Health during the 2nd quarter valued at $57,584,000. Susquehanna Fundamental Investments LLC boosted its stake in CVS Health by 27.9% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock valued at $39,302,000 after purchasing an additional 145,158 shares in the last quarter. Steph & Co. boosted its stake in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 288 shares in the last quarter. Douglas Lane & Associates LLC boosted its stake in CVS Health by 1.6% during the 1st quarter. Douglas Lane & Associates LLC now owns 1,084,256 shares of the pharmacy operator’s stock valued at $86,480,000 after purchasing an additional 16,840 shares in the last quarter. Finally, First Hawaiian Bank boosted its stake in CVS Health by 30.1% during the 2nd quarter. First Hawaiian Bank now owns 100,302 shares of the pharmacy operator’s stock valued at $5,924,000 after purchasing an additional 23,213 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

CVS has been the subject of a number of recent research reports. Wells Fargo & Company increased their price objective on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research report on Monday, August 12th. TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research report on Tuesday. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $68.00 price objective on shares of CVS Health in a research report on Wednesday, September 4th. Ten research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $74.05.

CVS Health Trading Up 1.0 %

CVS Health stock opened at $65.88 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The company has a market capitalization of $82.70 billion, a price-to-earnings ratio of 11.58, a PEG ratio of 0.81 and a beta of 0.54. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company’s fifty day moving average price is $58.67 and its two-hundred day moving average price is $61.25.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion for the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $2.21 earnings per share. On average, analysts forecast that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.04%. The ex-dividend date is Monday, October 21st. CVS Health’s dividend payout ratio is currently 46.75%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.